Stock market investment tips today and Tomorrow, intraday nifty and stocks Tips and call 19 Dec 2018, Nifty Trading Tips, nifty trend tomorrow, nifty stocks, nifty tips intrans, nifty tips provider, stock market investment for beginners, intraday stock tips, intraday trading intraday stocks watch today, best stocks to buy today and tomorrow, hot stocks to buy now, picks in shares of India 19 Dec 2018
--------------------------------------------------------------------------------------------------------
Product approval in European Union | Biocon, in a filing to exchanges, has said that Ogivri, a biosimilar Trastuzumab has been approved in the European Union (EU). The biosimilar is jointly developed by Biocon and Mylan.
“The European Commission has granted Marketing Authorization for Ogivri to our partner Mylan. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP} previously issued a positive opinion recommending approval of Ogivri as a biosimilar to Roche's Herceptin® (Trastuzumab) on October 18,2018,” the company said in the statement.
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer (EBC), metastatic breast cancer (MBC) and metastatic gastric cancer (MGC}.
For Quick Trial Contact:
✆ - 09699997717✔
✆ - 0731-6626191 ✔
Mail: info@ways2capital.com
✆ Join us on WhatsApp @ 89620-00225 ✆
✆ 24/7 Customer Care 1800-3010-2007 (Toll Free).
0 comments:
Post a Comment